All, This is a bit off topic, but I think this could be of general interest to folks. See below for information about the "Residential School on Medicinal Chemistry and Biology in Drug Discovery".
Sincerely, Corey -------------------------------- Subject: Residential School on Medicinal Chemistry and Biology in Drug Discovery (ResMed): A Comprehensive One-Week Course Dear all, The 29th Annual ResMed: Residential School on Medicinal Chemistry and Biology in Drug Discovery will be held on June 7 - June 12, 2015 at Drew University in Madison, NJ and is co-sponsored by the ACS MEDI Division. ResMed is a week-long graduate level course organized to provide an accelerated program for chemists, biologists and other industrial and academic scientists who wish to broaden their knowledge of drug discovery and development. The School's aim is to concentrate on the fundamentals that are useful in drug discovery spanning initial target validation through clinical development. The program provides ample opportunity for discussions with distinguished faculty from industry and academia. The purpose of the School is to provide a strong background in the principles of drug discovery and development to enhance collaborative drug discovery programs. Previous attendees with backgrounds in macromolecular crystallography have found the course of great value in their research projects. Information regarding ResMed can be accessed on our website: www.drew.edu/resmed<http://www.drew.edu/resmed> including our program and application. Please join us in our 29th year. We look forward to seeing you. Sincerely, Co-organizers, William J. Greenlee, Ph.D Vincent P. Gullo, Ph.D. Ronald J. Doll, Ph.D. Notice: This e-mail message, together with any attachments, contains information of Merck & Co., Inc. (2000 Galloping Hill Road, Kenilworth, New Jersey, USA 07033), and/or its affiliates Direct contact information for affiliates is available at http://www.merck.com/contact/contacts.html) that may be confidential, proprietary copyrighted and/or legally privileged. It is intended solely for the use of the individual or entity named on this message. If you are not the intended recipient, and have received this message in error, please notify us immediately by reply e-mail and then delete it from your system.